James B. Tananbaum

Foresite Capital Management Iv, Llc

Assets Managed

$237.082M

Holdings

Last Quarter

2026 - Q1

Filed Date

15d ago

Growth Rate

3.21%(2Q avg: 14.51%)

Sustained Growth

5 quarters

Portfolio positions

This chart displays the top 10 holdings in Foresite Capital Management Iv, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 8 positions.

Assets under management

The assets under management (AUM) of Foresite Capital Management Iv, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 5 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 237.082M in assets, with a quarterly growth rate of 3.21% and a 2-quarter average growth rate of 14.51%. The portfolio is managed by James B. Tananbaum, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
PHVS Pharvaris Nv Recent Activity	56.95%	$134.995M 4.779M shares@ $28.25 avg price
CYTK Cytokinetics Inc Recent Activity Increased 9.82%	14%	$33.172M 503,295 shares@ $65.91 avg price	Increased 9.82%
EIKN Eikon Therapeutics Inc Recent Activity New Position	8.68%	$20.564M 1.944M shares@ $10.59 avg price	New Position
LYEL Lyell Immunopharma Inc Recent Activity	6.78%	$16.056M 800,399 shares@ $20.07 avg price
RLAY Relay Therapeutics Inc Recent Activity	4.2%	$9.95M 1M shares@ $9.95 avg price
XENE Xenon Pharmaceuticals Inc Recent Activity	3.93%	$9.304M 160,000 shares@ $58.15 avg price
ALEC Alector Inc Recent Activity	3.53%	$8.357M 3.887M shares@ $2.15 avg price
MAZE Maze Therapeutics Inc Recent Activity Decreased -69.98%	1.98%	$4.683M 156,901 shares@ $29.86 avg price	Decreased -69.98%

1-8 of 8